Results 181 to 190 of about 12,023 (191)

Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis

Clinical Gastroenterology and Hepatology, 2014
Mark Osterman, Douglas Wolf, James Lewis   +2 more
exaly  

Prospective Multicenter Study Evaluating Fecal Calprotectin in Adult Acute Bacterial Diarrhea

American Journal of Medicine, 2008
Jürgen Stein
exaly  

Impact of disease location on fecal calprotectin levels in Crohn’s disease

Scandinavian Journal of Gastroenterology, 2015
Geert D'Haens, Kb Gecse
exaly  

Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease

Digestive and Liver Disease, 2018
Maria Chaparro, Vanesa Jusué, Javier P Gisbert   +2 more
exaly  

Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome

American Journal of the Medical Sciences, 2019
Seok-Hoon Lee, Kyu-Nam Kim
exaly  

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

Inflammatory Bowel Diseases, 2009
CARLOS Taxonera, A G Mcnicholl, Isabel Vera   +2 more
exaly  

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

Inflammatory Bowel Diseases, 2006
Lee Denson, Denson Lee A
exaly  

Effectiveness and Cost-effectiveness of Measuring Fecal Calprotectin in Diagnosis of Inflammatory Bowel Disease in Adults and Children

Clinical Gastroenterology and Hepatology, 2014
Kt Park, Zhuo Yang
exaly  

Fecal Excretion of Calprotectin in Colorectal Cancer Relationship to Tumor Characteristics

Scandinavian Journal of Gastroenterology, 2001
exaly  

Fecal Calprotectin Use in Inflammatory Bowel Disease and Beyond: A Mini-Review

Canadian Journal of Gastroenterology and Hepatology, 2015
exaly